The Changing Face of Dermatophytosis: A Call for Surveillance and Stewardship in Pakistan
DOI:
https://doi.org/10.66344/jpad.v36i3.3570Keywords:
Dermatophytosis, Trichophyton indotineae, Antifungal resistance, Antifungal stewardship, SurveillanceAbstract
Dermatophytosis is evolving from a predictable superficial infection into a challenging clinical problem due to antifungal resistance, especially the emergence and global dissemination of Trichophyton indotineae. Pakistan is not exempted from this emerging threat. Recent laboratory-based evidence from Karachi has isolated T. indotineae and terbinafine-non-wild-type Trichophyton isolates among patients with recalcitrant dermatophytosis, although these findings cannot estimate national prevalence. This editorial highlights the need to interpret these findings as an early warning sign that requires systematic surveillance. The potential contributors to treatment failure include inappropriate antifungal exposure, use of corticosteroid-containing combinations, diagnostic limitations and inappropriate treatment practices. Given the challenges of nationwide surveillance, a proportionate approach based on sentinel dermatology and mycology centres, strengthened laboratory capacity and standardized reporting is proposed. Antifungal stewardship should focus on accurate diagnosis, rational prescribing and timely investigation of recalcitrant disease. Pakistan-specific clinical guidance should evolve. The Journal of Pakistan Association of Dermatologists (JPAD) can act as platform for multicentre research, standardized reporting, consensus recommendations, education and multidisciplinary collaboration to translate emerging evidence into action.
References
1. Gupta AK, Venkataraman M, Hall DC, Cooper EA, Summerbell RC. The emergence of Trichophyton indotineae: implications for clinical practice. Int J Dermatol. 2023;62(7):857-61.
2. Gupta AK, Wang T, Mann A, Ravi SP, Talukder M, Lincoln SA, et al. Antifungal resistance in dermatophytes: review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineaeinfections. Expert Rev Anti Infect Ther. 2024;22(9):739-51. doi:10.1080/14787210.2024.2390629.
3. Jabet A, Normand AC, Brun S, Dannaoui E, Bachmeyer C, Piarroux R, et al. Trichophyton indotineae, from epidemiology to therapeutic. J Mycol Med. 2023;33(3):101383.
4. Khurana A, Sharath S, Sardana K, Chowdhary A. Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae. J Am Acad Dermatol. 2024;91(2):315-23.
5. Shahid M, Raheem T, Zaka S, Farooqi J, Naqvi SF, Talat H, et al. SQLE mutations and antifungal susceptibility profile of Trichophyton species isolated from patients with recalcitrant dermatophytosis: a laboratory-based study from Pakistan. Med Mycol. 2026;64(1):myaf127. doi:10.1093/mmy/myaf127.
6. Marbaniang YV, Leto D, Almohri H, Hasan MR. Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae. J Clin Microbiol. 2025;63(6):e01407-24. doi:10.1128/jcm.01407-24.
7. Rhodes J, Hui ST, Dellière S, Summerbell RC, Scott JA, Kaur A, et al. Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study. Lancet Microbe. 2026;7(2):101273.
8. Abdolrasouli A, Barton RC, Borman AM. Spread of antifungal-resistant Trichophyton indotineae, United Kingdom, 2017-2024. Emerg Infect Dis. 2025;31(1):192-4. doi:10.3201/eid3101.240923.
9. World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022.
10. Gupta AK, Susmita, Nguyen HC, Liddy A, Talukder M, Wang T, et al. Trichophyton indotineae: epidemiology, antifungal resistance and antifungal stewardship strategies. J Eur Acad Dermatol Venereol. 2026;40(1):29-45. doi:10.1111/jdv.20810.
11. Ahmad S. Emergent insights on the spread of antifungal-resistant Trichophyton indotineae dermatophyte: clonal expansion, adaptability dynamics and human-animal host adaptation. J Mycol Med. 2026;36(2):101608.
doi:10.1016/j.mycmed.2026.101608.
12. Sonego B, Corio A, Mazzoletti V, Zerbato V, Benini A, di Meo N, et al. Trichophyton indotineae, an emerging drug-resistant dermatophyte: a review of the treatment options. J Clin Med. 2024;13(12):3558. doi:10.3390/jcm13123558.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
